Harbin Honor Pharmaceutical Co., Ltd.
Future Three-Year (2026-2028) Shareholder Return Plan
Harbin Honor Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has formulated this Three-Year (2026-2028) Shareholder Return Plan to further promote the establishment of a scientific, sustainable, and stable dividend decision-making and supervision mechanism, actively reward investors, and guide investors in forming stable investment return expectations, in accordance with the "Company Law," "Securities Law," "Guiding No. 3 for Listed Company Supervision—Cash Dividends for Listed Companies," and other relevant laws, regulations, and the "Articles of Association." The specific content is as follows:
I. Factors Considered in Formulating the Company's Plan
The Company's shareholder dividend return plan for the next three years is an arrangement made based on a comprehensive analysis of the company's current operating development status, social capital costs, and external financing environment, fully considering the company's current and future profitability, cash flow status, development stage, project investment capital needs, and the banking credit and debt financing environment, balancing shareholders' short-term and long-term interests.
II. Principles for Formulating the Plan
The formulation of this plan shall comply with the relevant clauses on profit distribution in the "Articles of Association." It shall emphasize providing reasonable investment returns to shareholders while taking into account the company's actual operating conditions and sustainable development for the year. Based on fully considering shareholders' interests, the relationship between the company's short-term interests and long-term development shall be handled, a reasonable profit distribution plan shall be determined, and a plan for implementing the profit distribution policy for a certain period shall be formulated accordingly, to maintain the continuity and stability of the company's profit distribution policy.